Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease

Gut

Volumn 42, Issue 4, 1998, Pages 485-492

  Sido, B ^a   Hack, V ^b   Hochlehnert, A ^a   Lipps, H ^b   Herfarth, C ^a   Droge W ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Amino acids; Crohn's disease; Glutathione; Mucosa; Ulcerative colitis; glutamylcysteine synthetase

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ERYTHROCYTE; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN TISSUE; ILEUM MUCOSA; INTESTINE EPITHELIUM; MALE; MUSCLE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0031903014     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.4.485     Document Type: Article

References (54)

1. Mahida YR, Wu KC, Jewell DP. Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 1989;30:1362-70.
2. Williams JG. Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment. Ann R Coll Surg Engl 1990;72:253-62.
3. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988;33:6S-15S.
4. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
5. Williams JG, Hughes LE, Hallert MB. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 1990;31:187 93.
6. Grisham MB, Volkmer C, Tso P, et al. Metabolism of trinitrobenzene sulfonic acid by rat colon produces reactive oxygen species. Gastroenterology 1991;101:540-7.
7. Millar AD, Rampton DS, Chander CL, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996;39: 407-15.
8. Keshavarazian A, Sedghi S, Kanovsky J, et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 1992;103:177-85.
9. Grisham MB, MacDermott RP, Deitch EA. Oxidant defense mechanisms in the human colon. Inflammation 1990;6:669-80.
10. Babbs C. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992;13:169-81.
11. van der Vliet A, Bast A. Role of reactive oxygen species in intestinal diseases. Free Radic Biol Med 1992;12:499 513.
12. Iantomasi T, Marraccini P, Favilli F, et al. Glutathione metabolism in Crohn's disease. Biochem Med Metabol Biol 1994;53:87-91.
13. Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996;41:2078-86.
14. Ahnfelt-Ronne I, Nielssen OH. The anti-inflammatory moiety of sulfasalzine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions 1987;21:191-4.
15. Ahnfelt-Ronne I, Nielsen OH, Christensen A, et al. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990;98:1162 9.
16. Emerit J, Pelletier S, Likforman J, et al. Phase II trial of Superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic Res Commun 1991;12-13(Pt 2):563-9.
17. Niwa Y, Somiay K, Michelson AM, et al. Effect of liposomal-encapsulated Superoxide dismutase on active oxygen-related disorders. Free Radic Res Commun 1985;1: 137-53.
18. Simmonds NJ, Blake DR, Rampton DS. The effects of aminosalicylates and potential new drugs on mucosal reactive oxygen metabolite production in ulcerative colitis. Gut 1992;33(suppl):S7.
19. Tamai H, Levin S, Gaginella TS. Induction of colitis in rats by 2-2'-azobis(2-amidinopropane) dihydrochloride. Inflammation 1992;16:69 81.
20. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859-61.
21. Gross V, Arndt H, Andus T, et al. Free radicals in inflammatory bowel diseases. Pathophysiology and therapeutic implications. Hepatogastroenterol 1994;41:320-7.
22. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983;52:711-60.
23. Martensson J, Jain A, Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci USA 1990;87:1715-9.
24. Richman P, Meister A. Regulation of gamma-glutamylcysteine synthetase by nonallosteric feedback inhibition by glutathione. Biol Chem 1975;250:1422-6.
25. Eck H-P, Dröge W. Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and on the capacity to release cysteine. Biol Chem Hoppe-Seyler 1989;370:109-13.
26. Bannai S, Kitamura E. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem 1980;255:2372-6.
27. Meister A. Selective modification of glutathione metabolism. Science 1983;220:472-7.
28. Vincenzini MT, Favilli F, Iantomasi T. Intestinal uptake and transmembrane transport systems of intact GSH: characteristics and possible biological role. Biochim Biophys Acta 1992;1113:13-23.
29. Hagen TM, Wierzbicka GT, Sillau AH, et al. Bioavailability of dietary glutathione: effect on plasma concentrations. Am J Physiol 1990;259:G524-9.
30. Hagen TM, Wierzbicka GT, Bowman BB, et al. Fate of dietary glutathione: disposition in the gastrointestinal tract. Am J Physiol 1990;259:G530-5.
31. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
32. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalzine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298:82-6.
33. Eck H-P, Gmünder H, Hartmann M, et al. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe-Seyler 1989;370: 101-8.
34. Gmünder H, Eck HP, Benninghoff B, et al. Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. Cell Immunol 1990;129:32-46.
35. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinyl-pyridine. Anal Biochem 1980;106:207-12.
36. Lowry OH, Rosenbrough WJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265 75.
37. Seelig GF, Meister A. Glutathione biosynthesis; -/-glutamylcysteine synthetase from rat kidney. Methods Enzymol 1985;13:379 90.
38. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
39. Siebenlist U, Franzoso G, Brown K, Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994;10:405 55.
40. Ishii T, Sugita Y, Bannai S. Regulation of glutathione in mouse spleen lymphocytes by transport of cysteine. J Cell Physiol 1987;133:330-6.
41. Eck H-P, Drings P, Dröge W. Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma. J Cancer Res Clin Oncol 1989;115:571-4.
42. Hack V, Schmid D, Breitkreutz R, et al. Cystine levels, cystine flux and protein catabolism in cancer cachexia, HIV/SIV infection and senescence. FASEB J 1997;11:84-92.
43. Simmonds NJ, Allen RE, Stevens TR, et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992;103: 186 96.
44. Tamai H, Kachur JF, Grisham MB, et al. Scavenging effect of 5-aminosalicylic acid on neutrophil-derived oxidants. Possible contribution to the mechanism of action in inflammatory bowel disease. Biochem Pharmacol 1991;41:1001-6.
45. Williams JG, Hallett MB. The reaction of 5-amino-salicylic acid with hypochlorite. Implications for the mode of action in inflammatory bowel disease. Biochem Pharmacol 1989; 38:144 54.
46. Dallegri F, Ottonello L, Ballestrero A, et al. Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. Gut 1990;31:184 6.
47. Karmeli F, Rachmilewitz D. Cysteine and methionine: a novel modality to ameliorate tissue injury in experimental colitis [abstract]. Gastroenterology 1997;112:A1009.
48. Hack V, Gross A, Kinscherf R, et al. Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor-induced cachexia. FASEB J 1996;10:1219-26.
49. Bannai S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 1986;261: 2256 62.
50. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989;257:L163-73.
51. DeLucia AJ, Mustafa MG, Hussain MZ, et al. Ozone interaction with rodent lung. III. Oxidation of reduced glutathione and formation of mixed disulfides between protein and nonprotein sulfhydryls. J Clin Invest 1975;55:794 802.
52. Peters WHM, Roelofs MMJ, Nagengast FM, et al. Human intestinal glutathione S-transferases. Biochem J 1989;257: 471-6.
53. C-ornell JS, Meister A. Glutathione and γ-glutamyl cycle enzymes in crypt and villus tip cells of rat jejunal mucosa. Proc Natl Acad Sci USA 1976;73:420-2.
54. Hagen TM, Jones DP. Transepithelial transport of glutathione in vascularly perfused small intestine of rat. Am J Physiol 1987;252:G607-13.